• Гипотиреоз у детей (лекция для педиатров и врачей общей практики)

Гипотиреоз у детей (лекция для педиатров и врачей общей практики)

SOVREMENNAYA PEDIATRIYA.2017.6(86):17-27; doi 10.15574/SP.2017.86.17

Маменко М. Е.
Национальная медицинская академия последипломного образования имени П.Л. Шупика, г. Киев, Украина

Снижение функциональной активности щитовидной железы негативно влияет на рост, физическое и нервно-психическое развитие ребенка, формирование его интеллекта, активность обмена веществ и энергии. Малоспецифичная и стертая клиническая симптоматика гипотиреоза часто приводит к поздней диагностике, что снижает эффективность терапии. Особого внимания заслуживают врожденные и субклинические формы приобретенного гипотиреоза у детей как наиболее частые проявления тиреоидной гипофункции. Знания симптомов, методов первичной диагностики и возможностей современной терапии педиатрами и врачами общей практики является необходимым условием своевременного выявления случаев гипотиреоза в детской популяции и их адекватной коррекции.
Ключевые слова: гипотиреоз, дети, диагностика, лечение.

Литераура

 

1. Зелінська НБ. (2015). Вроджений гіпотиреоз. Український журн дитячої ендокринол. 1: 67—68. http://nbuv.gov.ua/UJRN/ujde_2015_1_14.

2. Зелінська НБ. (2015). Ювенільний гіпотиреоз. Український журнал дитячої ендокринології. 1: 69—70. http://nbuv.gov.ua/UJRN/ujde_2015_1_15.

3. Маменко МЕ. (2013). Гипотиреоз у детей. Дитячий лікар. 2: 32—39.

4. Протокол надання медичної допомоги дітям за спеціальністю «Дитяча ендокринологія». Наказ МОЗ України №254 від 27.04.2006 р. (2006). Київ: 88.

5. Mathai S, Cutfield WS, Gunn AJ et al. (2008). A novel therapeutic paradigm to treat congenital hypothyroidism. Clin Endocrinol. 69: 142—147. https://doi.org/10.1111/j.1365-2265.2008.03172.x; PMid:18598275

6. Hennessey JV, Malabanan AO, Haugen BR, Levy EG. (2010). Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Pract. 16: 357—370. https://doi.org/10.4158/EP0362.OR; PMid:20551006

7. Mechanick JI, Brett EM, Chausmer AB et al. (2003). American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. Endocr Pract. 9: 417—470. https://doi.org/10.4158/EP.9.5.417; PMid:14583426

8. Gharib H, Tuttle RM, Baskin HJ et al. American Association of Clinical Endocrinologists; American Thyroid Association; Endocrine Society 2005 Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 15: 24—28; response 32—23.

9. Shakir KM, Turton D, Aprill BS et al. (2000). Anemia: a cause of intolerance to thyroxine sodium. Mayo Clin Proc. 75: 189—192. https://doi.org/10.4065/75.2.189; https://doi.org/10.1016/S0025-6196(11)64193-1

10. Angermayr L, Clar C. (2004). Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003819. https://doi.org/10.1002/14651858.CD003819.pub2; PMid:15106221

11. Virilic J, Bassotti G, Santaguida MG et al. (2012). Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 97: 419—422. https://doi.org/10.1210/jc.2011-1851; PMid:22238404

12. Balhara B, Misra M, Levitsky LL. (2011). Clinical monitoring guidelines for congenital hypothyroidism: laboratory outcome data in the first year of life. J Pediatr. 158: 532—537. https://doi.org/10.1016/j.jpeds.2010.10.006; PMid:21094953

13. Beck-Peccoz P. (2011). Treatment of central hypothyroidism. Clin Endocrinol. 74: 671—672. https://doi.org/10.1111/j.1365-2265.2011.04037.x; PMid:21521306

14. Biondi B, Cooper DS. (2008). The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 29: 76—131. https://doi.org/10.1210/er.2006-0043; PMid:17991805

15. Biondi B, Wartofsky L. (2014). Treatment with thyroid hormone. Endocr Rev. 35: 433—512. https://doi.org/10.1210/er.2013-1083; PMid:24433025

16. Brent GA. (2012). Mechanisms of thyroid hormone action. J Clin Invest. 122: 3035—3043. https://doi.org/10.1172/JCI60047; PMid:22945636 PMCid:PMC3433956

17. Brown RS. (2009). Chapter 15b — Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence. URL: http://www.thyroidmanager.org.

18. De Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child. 94: 33—37. https://doi.org/10.1136/adc.2007.134841; PMid:18703546

19. Visser WE, van Mullem AA, Visser TJ, Peeters RP. (2013). Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. Clin Endocrinol. 79: 595—605. https://doi.org/10.1111/cen.12281

20. Nebesio TD, Wise MD, Perkins SM, Eugster EA. (2011). Does clinical management impact height potential in children with severe acquired hypothyroidism? J Pediatr Endocrinol Metab. 24: 893—896. https://doi.org/10.1515/JPEM.2011.310; PMid:22308838

21. Choi YH, Choi WY, Kang HC et al. (2012). Drug rash induced by levothyroxine tablets. Thyroid. 22: 1090. https://doi.org/10.1089/thy.2011.0462; PMid:22962862

22. Eisenberg M, Distefano JJ. (2009). TSH-based protocol, tablet instability, and absorption effects on LT4 bioequivalence. Thyroid. 19: 103—110. https://doi.org/10.1089/thy.2008.0148; PMid:19191742 PMCid:PMC2858298

23. Monzani A, Prodam F, Rapa A et al. (2013). Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol. 168: R1—R11. https://doi.org/10.1530/EJE-12-0656; PMid:22989466

24. Leger J, Olivieri A, Donaldson M et al. (2014). European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. J Clin Endocrinol Metab. 99: 363—384. https://doi.org/10.1210/jc.2013-1891; PMid:24446653 PMCid:PMC4207909

25. Lazarus J, Brown RS, Daumerie C et al. (2014). European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children.

26. Carswell JM, Gordon JH, Popovsky E et al. (2013). Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J Clin Endocrinol Metab. 98: 610—617. https://doi.org/10.1210/jc.2012-3125; PMid:23264396 PMCid:PMC3565118

27. Lomenick JP, Wang L, Ampah SB et al. (2013). Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism. J Clin Endocrinol Metab. 98: 653-658. https://doi.org/10.1210/jc.2012-3558; PMid:23293325

28. Taylor PN, Okosieme OE, Dayan CM, Lazarus JH. (2014). Impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol. 170(1): 1—15. https://doi.org/10.1530/EJE-13-0651; PMid:24088547

29. John-Kalarickal J, Pearlman G, Carlson HE. (2007). New medications which decrease levothyroxine absorption. Thyroid. 17: 763—765. https://doi.org/10.1089/thy.2007.0060; PMid:17725434

30. Kaplowitz PB. (2010). Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol: 281453. https://doi.org/10.1186/1687-9856-2010-281453; PMid:20628588 PMCid:PMC2901603

31. Kaptein EM, Beale E, Chan LS. (2009). Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 94: 3663—3675. https://doi.org/10.1210/jc.2009-0899; PMid:19737920

32. Kundra P, Burman KD. (2012). The effect of medications on thyroid function tests. Med Clin North Am. 96: 283—295. https://doi.org/10.1016/j.mcna.2012.02.001; PMid:22443976

33. La Franchi SH, Austin J. (2007). How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab. 20: 559—578.

34. Lania A, Persani L, Beck-Peccoz P. (2008). Central hypothyroidism. Pituitary. 11: 181—186. https://doi.org/10.1007/s11102-008-0122-6; PMid:18415684

35. Devdhar M, Drooger R, Pehlivanova M et al. (2011). Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid. 21: 821—827. https://doi.org/10.1089/thy.2011.0029; PMid:21751885 PMCid:PMC3148125

36. Razvi S, Weaver JU, Butler TJ, Pearce SH. (2012). Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 172: 811—817. https://doi.org/10.1001/archinternmed.2012.1159; PMid:22529180

37. Cerbone M, Bravaccio C, Capalbo D et al. (2011). Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol. 164: 591—597. https://doi.org/10.1530/EJE-10-0979; PMid:21292920

38. Lomenick JP, El-Sayyid M, Smith WJ. (2008). Effect of levo-thyroxine treatment on weight and body mass index in children with acquired hypothyroidism. J Pediatr. 152: 96—100. https://doi.org/10.1016/j.jpeds.2007.06.006; PMid:18154908

39. Magen E, Mishal J. (2012). The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis. Int J Dermatol. 51: 94—97. https://doi.org/10.1111/j.1365-4632.2011.05172.x; PMid:22182385

40. Munoz-Torres M, Varsavsky M, Alonso G. (2006). Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid. 16: 1171—1173. https://doi.org/10.1089/thy.2006.16.1171; PMid:17123345

41. Lazar L, Frumkin RB, Battat E et al. (2009). Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab. 94: 1678—1682. https://doi.org/10.1210/jc.2008-2615; PMid:19240148

42. O'Grady MJ, Cody D. (2011). Subclinical hypothyroidism in childhood. Arch Dis Child. 96: 280—284. https://doi.org/10.1136/adc.2009.181800; PMid:20413616

43. Raine Joseph E, Malcolm DC Donaldson, John W Gregory, Guy Van Vilet. (2010). Practical Endocrinology and Diabetes in Children. 3-thd edition. Wiley-Blackwell: 258.

44. Practical Paediatric Endocrinology in a Limited Resource Setting. Editor M Zacharin. (2011). Melburne, Australia: 320.

45. Rajput R, Chatterjee S, Rajput M. (2011). Can levothyroxine be taken as evening dose? Comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism. J Thyroid Res: 505239. https://doi.org/10.4061/2011/505239

46. Refetoff S, Dumitrescu AM. (2007). Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 21: 277—305. https://doi.org/10.1016/j.beem.2007.03.005; PMid:17574009

47. Ittermann T, Thamm M, Wallaschofski H et al. (2012). Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab. 97: 828—834. https://doi.org/10.1210/jc.2011-2768; PMid:22205713

48. Perez L, Araki FS, Graf H, de Carvalho GA. (2013). Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 23: 779—784. https://doi.org/10.1089/thy.2012.0435; PMid:23363386

49. Hollowell JG, Staehling NW, Flanders WD et al. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 87: 489—499. https://doi.org/10.1210/jcem.87.2.8182; PMid:11836274

50. Surks MI, Goswami G, Daniels GH. (2005). The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 90: 5489—5496. https://doi.org/10.1210/jc.2005-0170; PMid:16148346

51. Bugdaci MC, Zuhur SS, Sokmen M et al. (2011). The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine. Helicobacter. 16: 124—130. https://doi.org/10.1111/j.1523-5378.2011.00830.x; PMid:21435090

52. Pacifico L, Anania C, Ferraro F et al. (2012). Thyroid function in childhood obesity and metabolic comorbidity. Clin Chim Acta. 413: 396—405. https://doi.org/10.1016/j.cca.2011.11.013; PMid:22130312

53. Almeida OP, Alfonso H, Flicker L et al. (2011). Thyroid hormones and depression: the Health in Men study. Am J Geriatr Psychiatry. 19: 763—770. https://doi.org/10.1097/JGP.0b013e31820dcad5; PMid:21873831

54. U.S. Food and Drug Administration. Questions and answers on levothyroxine sodium products. URL: http://www.fda.gov/Drugs/DrugSafety/Postmarket Drug Safety Information for Patients and Providers/ucm161266.htm

55. Bagnasco M, Minciullo PL, Saraceno GS et al. (2011). Urticaria and thyroid autoimmunity. Thyroid. 21: 401—410. https://doi.org/10.1089/thy.2010.0103; PMid:21323598

56. Van den Berghe G. (2014). Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 24: 1456—1465. https://doi.org/10.1089/thy.2014.0201; PMid:24845024 PMCid:PMC4195234

57. Vita R, Benvenga S. (2014). Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule. Endocr Pract. 20(3): 38—41. https://doi.org/10.4158/EP13316.CR; PMid:24246350

58. Zamfirescu I, Carlson HE. (2011). Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 21: 483—486. https://doi.org/10.1089/thy.2010.0296; PMid:21595516 PMCid:PMC3092723

59. Zimmermann MB. (2009). Iodine Deficiency. Endocrine Reviews. 30(4): 376—408. https://doi.org/10.1210/er.2009-0011; PMid:19460960

60. Zimmermann MB, Jooste PL, Pandav CS. (2008). Iodine-deficiency disorders. Lancet. 372(9645): 1251—1262. https://doi.org/10.1016/S0140-6736(08)61005-3